Your browser doesn't support javascript.
loading
Outcomes of modified-eam conditioned autologous non-cryopreserved hematopoietic sct for lymphoma. A retrospective single-centre study.
Bekadja, M A; Talhi, S; Amani, K; Osmani, S; Brahimi, M; Mazari, M A; Krim, A; Yafour, N; Entasoltan, B; Bouchama, S; Charef, L; Serradj, F; Bouhass, R; Arabi, A.
Afiliación
  • Bekadja MA; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria. mabekadja@yahoo.fr.
  • Talhi S; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Amani K; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Osmani S; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Brahimi M; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Mazari MA; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Krim A; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Yafour N; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Entasoltan B; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Bouchama S; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Charef L; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Serradj F; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Bouhass R; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
  • Arabi A; Department of Hematology and Cell Therapy, Etablissement Hospitalier Universitaire (EHU) 1st November, University of Oran, Oran, Algeria.
Bone Marrow Transplant ; 53(12): 1596-1598, 2018 12.
Article en En | MEDLINE | ID: mdl-29895930
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante Autólogo / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Linfoma Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Argelia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante Autólogo / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Linfoma Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Argelia Pais de publicación: Reino Unido